Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) for Gastric Reduction

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Obesity
Interventions
DEVICE

ENDOMINA

Endomina will be introduced into the stomach over guide wires and then fixed to the endoscope. The procedure will include the placement of 4-6 transmural anterior-posterior sutures after argon plasma coagulation of the tissue opposition areas in order to ensure persistence of the pouch reduction. Patient will be kept overnight after the procedure.

Trial Locations (1)

1070

Erasme Hospital , ULB, Brussels

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER

NCT02534662 - Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) for Gastric Reduction | Biotech Hunter | Biotech Hunter